Thought Leadership
 
Email Page
U.S. Government Accuses Gilead of Infringing HIV-Prevention Drug Regimen Patents
November 8, 2019
Thomas Long
IP Law Daily

Axinn partner Chad Landmon was quoted in the IP Law Daily article, "U.S. Government Accuses Gilead of Infringing HIV-Prevention Drug Regimen Patents."

Click here to access the article. A subscription is required.